Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;76(10):3194-3196.
doi: 10.1111/all.14981. Epub 2021 Jul 3.

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Anne-Sophie Darrigade  1 , Hélène Théophile  2 , Paola Sanchez-Pena  2 , Brigitte Milpied  1 , Marianne Colbert  3 , Stéphane Pedeboscq  4 , Thierry Pistone  5 , Marie-Laure Jullié  6 , Julien Seneschal  1   7
Affiliations

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Anne-Sophie Darrigade et al. Allergy. 2021 Oct.
No abstract available

Keywords: Pfizer-BioNTech mRNA vaccine; SARS-CoV-2; delayed hypersensitivity; intradermal test; sweet syndrome.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Sweet syndrome lesions (A) First localization appeared 24 h after the vaccine injection on the back. (B) Erythematous papulosis on the left shoulder. (C) (1) Cutaneous tests: Positive IDR with SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine diluted to 1/10e at day 5. (2) Patch test with pur SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine in healed skin. (3) Patch test with pur SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine in normal skin
FIGURE 2
FIGURE 2
A‐ HEx5: papillary dermal edema, interstitial, perivascular and periadnexal superficial and deep dermal polymorphous inflammatory infiltrate. (B) HEx20: leucocytoclastic vasculitis, eosinophils (white arrow), perivascular lymphocytes, and interstitial neutrophils. (C) HEx3: perivascular and periadnexal superficial and deep lymphocytic infiltrate
See this image and copyright information in PMC

References

    1. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45(6):321‐328. - PubMed
    1. Rosenblatt AE, Stein SL. Cutaneous reactions to vaccinations. Clin Dermatol. 2015;33(3):327‐332. - PubMed
    1. Corbeddu M, Diociaiuti A, Vinci MR, et al. Transient cutaneous manifestations after administration of Pfizer‐BioNTech COVID‐19 Vaccine: an Italian single centre case series. J Eur Acad Dermatol Venereol. 2021. 10.1111/jdv.17268 - DOI - PMC - PubMed
    1. Banerji A, Wickner PG, Saff R, et al. mRNA Vaccines to Prevent COVID‐19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. J Allergy Clin Immunol Pract. 2020;S2213–2198(20):31411‐31412. - PMC - PubMed
    1. Bianchi L, Biondi F, Hansel K, Murgia N, Tramontana M, Stingeni L. Skin tests in urticaria/angioedema and flushing to Pfizer‐BioNTech SARS‐CoV‐2 vaccine: Limits of intradermal testing. Allergy. 2021;76:2605‐2607. 10.1111/all.14839 - DOI - PMC - PubMed